Vimarsana
Biggest News Aggregation in the World

Page 17 - Bo Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bo Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bo Wang Today - Breaking & Trending Today

Candidate coronavirus vaccines show promising results in early animal testing - Vimarsana News

Candidate coronavirus vaccines show promising results in early animal testing

Candidate coronavirus vaccines show promising results in early animal testing A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing. The candidate coronavirus vaccines, created by Virginia Tech's University Distinguished Professor X.J. Meng and UVA Health's Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV). The researchers have recently published their findings in the Proceedings of the National Academy of Science...

Virginia Tech and UVA virologists develop broadly protective coronavirus vaccines - Vimarsana News

Virginia Tech and UVA virologists develop broadly protective coronavirus vaccines

 E-Mail IMAGE: X.J. Meng, University Distinguished Professor in the Virginia-Maryland College of Veterinary Medicine and founding director of the new center tackling infectious disease in the Fralin Life Sciences Institute at Virginia... view more  Credit: Virginia Tech A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing. The candidate coronavirus vaccines, created by Virginia Tech's University Distinguished Professor X.J. Meng and UVA Health's Professor Steven L. Zeichner, prevented...

Cyclica : Teams Up with Top-Tier Academic Institutions to Identify a Repurposed COVID Drug - Vimarsana News

Cyclica : Teams Up with Top-Tier Academic Institutions to Identify a Repurposed COVID Drug

New findings accelerated by Cyclica’s drug discovery platform suggest lung cancer drug capmatinib demonstrates robust antiviral effects in experimental COVID-19 models. ...

Cyclica, academics team up to investigate COVID-19 treatment - Vimarsana News

Cyclica, academics team up to investigate COVID-19 treatment

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatment’s potential in treating COVID-19. Cyclica, a company specializing in data-driven drug discovery, has determined that the lung-cancer drug capmatinib shows evidence of attenuating the impact of coronavirus. The firm made the discovery via collaboration with Ryerson, the Vector Institute, and other Canadian institutions; funding came through COVID-19 grants from the Canadian Institute for Advanced Research (CIFAR) and Natural Sciences and Engineering...

Researchers discover deep learning model to maximise lifespan after liver transplant - Vimarsana News

Researchers discover deep learning model to maximise lifespan after liver transplant

Researchers discover deep learning model to maximise lifespan after liver transplant ANI | Updated: Apr 13, 2021 07:27 IST Toronto [Canada], April 13 (ANI): Researchers from University Health Network have developed and validated an innovative deep learning model to predict a patient's long-term outcome after receiving a liver transplant. This model is the result of a collaboration between the Ajmera Transplant Centre and Peter Munk Cardiac Centre. The study, published in Lancet Digital Health, shows it can significantly improve long-term survival and qual...

Source: aninews.in